US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 17.965
  • +0.215+1.21%
Trading Jul 22 14:46 ET
2.97BMarket Cap0.00P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ACADIA Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

205.83M

+73.75%
EPS(YoY)

0.10

+137.04%
Analyst Rating

Strong Buy

Jul 16, 2024

ACADIA Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 250.198M--
--2024/Q2-- / 236.003M--
May 8, 20242024/Q1205.831M / 208.582M--
Feb 27, 20242023/Q4231.041M / 223.801M--
Nov 2, 20232023/Q3211.699M / 189.620M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 250.198M--
--2024/Q2-- / 236.003M--
May 8, 20242024/Q1205.831M / 208.582M--
Feb 27, 20242023/Q4231.041M / 223.801M--
Nov 2, 20232023/Q3211.699M / 189.620M--

Unlock Free Earnings Estimates

ACADIA Pharmaceuticals Earnings Reports

  • ACADIA Pharmaceuticals | 10-Q: Quarterly report

    May 9 15:44 ET

  • ACADIA Pharmaceuticals | 10-K: Annual report

    Feb 28 14:10 ET

  • ACADIA Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 18:33 ET

  • ACADIA Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 19:29 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 16, 2024

    Strong Buy

    • Buy

      76.47%

    • Hold

      23.53%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg